Abbott
Abbott appears in 38 analyzed articles across the measured technology press. Recent coverage is easing, counting every mention over recent months. This page shows the public snapshot: movement, coverage mix, recent sources, and what drove the latest change.
Compass measures press coverage, not Abbott's product quality, business performance, or market value.
Counting every mention, coverage of Abbott is easing — it appears in 38 analyzed articles across the technology press.
What Abbott coverage is made of over time: story type, claim stage as reported, and press framing. This measures the coverage, not the product.
Across 34 classified coverage items, one item is 2.9 percentage points — read the shares below as the shape of a small sample, not as figures precise to the point.
Story type and claim stage are shares of the 34 classified coverage items in this window.
How to read this
The stream below stacks each month's coverage by the lens you choose: Tone (how the press frames the story — promotional, skeptical, critical, or neutral), Story type (launches, funding, lawsuits, partnerships…), or Stage — how far the reported claim has gone: speculation → announcement → launch → results.
Taller bands mean more coverage that month; the dots beneath mark notable non‑neutral events. Every signal is sourced and dated.
How this is counted — why the article numbers differ
38 articles mention Abbott across the corpus. The coverage make-up above is measured on the 22 of them that were read into dated, classified coverage items — and one article can produce more than one item, because story type, claim stage and framing are read separately.
- regulation Abbott halted new Texas data center permits pending an ERCOT audit.
- lawsuit Abbott will pay $385 million to settle state, federal, and civil lawsuits over contamination issues at its Michigan baby formula plant in early 2022.
- Abbott halts new Texas data center permits pending ERCOT auditData Center Dynamics
- Abbott Settles Baby Formula Claims For $385 MillionForbes - Innovation
- FDA Approves First Wearable Device to Monitor Glucose, Ketone LevelsSlashdot
As of 8 Oct 2026 · corpus coverage 94% · 358,204 articles. Correlational & coverage-limited.
- ✓
This snapshotDirection, footprint & coverage make-up — free, no account, always
- 🔒
Full history & coverage trailMonth-by-month make-up & every cited source
- 🔒
ConnectionsThe topics it's most often covered alongside
- 🔒
Compare & exportBenchmark vs. other topics; export the source pack
- 🔒
Watchlist & alertsGet pinged when the make-up or direction shifts